Page 5 - Mesenchymal Stem cells, Exosomes and vitamins in the fight aginst COVID

Chemistry and Physics of Lipids 234 (2021) 105009
L. Rezakhani et al.
Golchin, A., Seyedjafari, E., Ardeshirylajimi, A., 2020. Mesenchymal stem cell therapy Sethupathy, P., Megraw, M., Hatzigeorgiou, A.G., 2006. A guide through present
for COVID-19: present or future. Stem Cell Rev. Rep. 1–7. computational approaches for the identification of mammalian microRNA targets.
Grein, J., Ohmagari, N., Shin, D., Diaz, G., Asperges, E., Castagna, A., et al., 2020. Nat. Methods 3 (11), 881–886.
Compassionate use of remdesivir for patients with severe Covid-19. N. Engl. J. Med. Sheahan, T.P., Sims, A.C., Leist, S.R., Sch¨ afer, A., Won, J., Brown, A.J., et al., 2020.
382 (24), 2327–2336. Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir,
Gupta, S., Krishnakumar, V., Sharma, Y., Dinda, A.K., Mohanty, S., 2020. Mesenchymal and interferon beta against MERS-CoV. Nat. Commun. 11 (1).
stem cell derived exosomes: a nano platform for therapeutics and drug delivery in Shetty, A.K., 2020. Mesenchymal stem cell infusion shows promise for combating
combating COVID-19. Stem Cell Rev. Rep. 1–11. coronavirus (COVID-19)-induced pneumonia. Aging Dis. 11 (2), 462.
Ivashchenko, A., Rakhmetullina, A., Aisina, D., 2020. How miRNAs Can Protect Humans Shu, L., Niu, C., Li, R., Huang, T., Wang, Y., Huang, M., et al., 2020. Treatment of severe
From Coronaviruses COVID-19, SARS-CoV, and MERS-CoV. COVID-19 with human umbilical cord mesenchymal stem cells. Stem Cell Res. Ther.
Ji, F., Li, L., Li, Z., Jin, Y., Liu, W., 2020. Mesenchymal stem cells as a potential treatment 11 (1), 1–11.
for critically ill patients with coronavirus disease 2019. Stem Cells Transl. Med. 9, Singh, S., Narang, A.S., Mahato, R.I., 2011. Subcellular fate and off-target effects of
813–814. siRNA, shRNA, and miRNA. Pharm. Res. 28 (12), 2996–3015.
Kass, D.A., Duggal, P., Cingolani, O., 2020. Obesity could shift severe COVID-19 disease Sokolova, V., Ludwig, A.-K., Hornung, S., Rotan, O., Horn, P.A., Epple, M., et al., 2011.
to younger ages. Lancet (London, England). Characterisation of exosomes derived from human cells by nanoparticle tracking
Kesimer, M., Scull, M., Brighton, B., DeMaria, G., Burns, K., O’Neal, W., et al., 2009. analysis and scanning electron microscopy. Colloids Surf. B Biointerfaces 87 (1),
Characterization of exosome-like vesicles released from human tracheobronchial 146–150.
ciliated epithelium: a possible role in innate defense. Faseb J. 23 (6), 1858–1868. Stern-Ginossar, N., Thompson, S.R., Mathews, M.B., Mohr, I., 2019. Translational control
Kronbichler, A., Kresse, D., Yoon, S., Lee, K.H., Effenberger, M., Shin, J.I., 2020. in virus-infected cells. Cold Spring Harb. Perspect. Biol. 11 (3), a033001.
Asymptomatic patients as a source of COVID-19 infections: a systematic review and Th´ ery, C., Zitvogel, L., Amigorena, S., 2002. Exosomes: composition, biogenesis and
meta-analysis. Int. J. Infect. Dis. 98, 180–186. function. Nat. Rev. Immunol. 2 (8), 569–579.
Kumar, S., Zhi, K., Mukherji, A., Gerth, K., 2020. Repurposing antiviral protease Vader, P., Mol, E.A., Pasterkamp, G., Schiffelers, R.M., 2016. Extracellular vesicles for
inhibitors using extracellular vesicles for potential therapy of COVID-19. Viruses 12 drug delivery. Adv. Drug Deliv. Rev. 106, 148–156.
(5), 486. Wan, Y., Shang, J., Graham, R., Baric, R.S., Li, F., 2020. Receptor recognition by the
Lamichhane, T.N., Sokic, S., Schardt, J.S., Raiker, R.S., Lin, J.W., Jay, S.M., 2015. novel coronavirus from Wuhan: an analysis based on decade-long structural studies
Emerging roles for extracellular vesicles in tissue engineering and regenerative of SARS coronavirus. J. Virol. 94 (7).
medicine. Tissue Eng. Part B Rev. 21 (1), 45–54. Witwer, K.W., Buz´ as, E.I., Bemis, L.T., Bora, A., L¨ asser, C., L¨ otvall, J., et al., 2013.
Lee, P.-I., Hu, Y.-L., Chen, P.-Y., Huang, Y.-C., Hsueh, P.-R., 2020. Are children less Standardization of sample collection, isolation and analysis methods in extracellular
susceptible to COVID-19? J. Microbiol. Immunol. Infect. 53 (3). vesicle research. J. Extracell. Vesicles 2 (1), 20360.
Leng, Z., Zhu, R., Hou, W., Feng, Y., Yang, Y., Han, Q., et al., 2020. Transplantation of Xu, X., Chen, P., Wang, J., Feng, J., Zhou, H., Li, X., et al., 2020. Evolution of the novel
ACE2-mesenchymal stem cells improves the outcome of patients with COVID-19 coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for
pneumonia. Aging Dis. 11 (2), 216. risk of human transmission. Sci. China Life Sci. 63 (3), 457–460.
Lu, R., Zhao, X., Li, J., Niu, P., Yang, B., Wu, H., et al., 2020. Genomic characterisation Yekta, S., Shih, I.-h, Bartel, D.P., 2004. MicroRNA-directed cleavage of HOXB8 mRNA.
and epidemiology of 2019 novel coronavirus: implications for virus origins and Science 304 (5670), 594–596.
receptor binding. Lancet 395 (10224), 565–574. Zhao, R.C., 2020. Stem cell-based therapy for coronavirus disease 2019. Stem Cells Dev.
Metcalfe, S.M., 2020. Mesenchymal stem cells and management of COVID-19 (ja).
pneumonia. Med. Drug Discovery, 100019. Zhou, L., Lim, M.Y.T., Kaur, P., Saj, A., Bortolamiol-Becet, D., Gopal, V., et al., 2018.
Rahmati, S., Shojaei, F., Shojaeian, A., Rezakhani, L., Dehkordi, M.B., 2020. An overview Importance of miRNA stability and alternative primary miRNA isoforms in gene
of current knowledge in biological functions and potential theragnostic applications regulation during Drosophila development. Elife 7, e38389.
of exosomes. Chem. Phys. Lipids 226, 104836. Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., et al., 2020.
L Rezakhani MA, E Sharifi, M Soleimannejad, A Alizadeh. Isolation and characterization A pneumonia outbreak associated with a new coronavirus of probable bat origin.
of crab hemolymph exosomes and its effects on breast cancer cells Cell journal Nature 579 (7798), 270–273.
(Yakhteh). 2022;4T1 (inpress). Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., et al., 2020. A novel coronavirus
Sengupta, V., Sengupta, S., Lazo, A., Woods, P., Nolan, A., Bremer, N., 2020. Exosomes from patients with pneumonia in China, 2019. N. Engl. J. Med. 395 (10236),
derived from bone marrow mesenchymal stem cells as treatment for severe COVID- 1544–1545.
19. Stem Cells Dev. 747–754.

5